Crinetics Pharmaceuticals, Inc.
CRNXDelisted Sep 1, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001658247
Crinetics Pharmaceuticals, Inc. was delisted on Sep 1, 2026; its insiders filed their last Form 4 on Sep 1, 2026; 267 institutions reported holding it in 13F filings for Q2 2026, worth $4.63B in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Crinetics Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 234
- +32 vs. Q1 2024
- Shares held
- 82.5M
- +2.12M (+2.6%) vs. Q1 2024
- Total value
- $3.69B
- −$65.9M (−1.8%) vs. Q1 2024
- New holders
- 48
- 103 more added
- Sold out
- 16
- 57 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 267 | $4.63B |
| Q1 2026 | 244 | $4.46B |
| Q4 2025 | 242 | $5.20B |
| Q3 2025 | 225 | $4.49B |
| Q2 2025 | 222 | $3.01B |
| Q1 2025 | 227 | $3.42B |
| Q4 2024 | 247 | $5.10B |
| Q3 2024 | 235 | $4.32B |
| Q2 2024 | 234 | $3.69B |
| Q1 2024 | 203 | $3.76B |
| Q4 2023 | 181 | $2.51B |
| Q3 2023 | 172 | $2.04B |
| Q2 2023 | 140 | $974.1M |
| Q1 2023 | 129 | $884.3M |
| Q4 2022 | 122 | $1.00B |
| Q3 2022 | 122 | $1.01B |
| Q2 2022 | 111 | $944.5M |
| Q1 2022 | 116 | $997.4M |
| Q4 2021 | 118 | $1.26B |
| Q3 2021 | 94 | $708.2M |
| Q2 2021 | 83 | $616.9M |
| Q1 2021 | 80 | $465.3M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Crinetics Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 546,234 | $24.5M | 0.06% | +3,526+0.6% | Added |
| Dimensional Fund Advisors LP | 546,759 | $24.5M | 0.01% | −94,043−14.7% | Reduced |
| StemPoint Capital LP | 551,095 | $24.7M | 7.26% | −68,694−11.1% | Reduced |
| MPM Oncology Impact Management LP | 557,184 | $25.0M | 3.88% | +76,596+15.9% | Added |
| Ikarian Capital, LLC | 588,818 | $26.4M | 8.23% | −54,933−8.5% | Reduced |
| Charles Schwab Investment Management Inc | 597,049 | $26.7M | 0.01% | +118,517+24.8% | Added |
| Northern Trust Corp | 606,037 | $27.1M | 0.00% | +4,653+0.8% | Added |
| Ensign Peak Advisors, Inc | 616,227 | $27.6M | 0.05% | −5,280−0.8% | Reduced |
| Goldman Sachs Group Inc | 649,190 | $29.1M | 0.01% | −214,917−24.9% | Reduced |
| Schonfeld Strategic Advisors LLC | 653,557 | $29.3M | 0.23% | +518,264+383.1% | Added |
| Eventide Asset Management, LLC | 735,088 | $32.9M | 0.56% | −324,545−30.6% | Reduced |
| Morgan Stanley | 838,625 | $37.6M | 0.00% | +226,425+37.0% | Added |
| Franklin Resources Inc | 861,422 | $38.6M | 0.01% | +448,213+108.5% | Added |
| Lord, Abbett & Co. LLC | 887,921 | $39.8M | 0.13% | −76,647−7.9% | Reduced |
| Novo Holdings A/S | 1,000,000 | $44.8M | 2.41% | −98,600−9.0% | Reduced |
| Artal Group S.A. | 1,066,064 | $47.7M | 1.23% | −324,413−23.3% | Reduced |
| First Light Asset Management, LLC | 1,200,508 | $53.8M | 4.71% | −489,669−29.0% | Reduced |
| OrbiMed Advisors LLC | 1,280,800 | $57.4M | 1.22% | −104,200−7.5% | Reduced |
| T. Rowe Price Investment Management, Inc. | 1,347,210 | $60.3M | 0.04% | −1,307,519−49.3% | Reduced |
| Cormorant Asset Management, LP | 1,350,000 | $60.5M | 3.52% | +200,000+17.4% | Added |
| Perceptive Advisors LLC | 1,476,203 | $66.1M | 1.60% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,678,387 | $75.2M | 0.01% | +276,984+19.8% | Added |
| Janus Henderson Group PLC | 2,455,661 | $110.0M | 0.06% | +477,489+24.1% | Added |
| Paradigm Biocapital Advisors LP | 2,513,302 | $112.6M | 4.31% | −611,447−19.6% | Reduced |
| Jennison Associates LLC | 2,780,144 | $124.5M | 0.08% | −37,710−1.3% | Reduced |
| Point72 Asset Management, L.P. | 2,780,856 | $124.6M | 0.40% | −2,168,630−43.8% | Reduced |
| State Street Corp | 2,812,923 | $126.0M | 0.01% | −442,330−13.6% | Reduced |
| FMR LLC | 4,096,795 | $183.5M | 0.01% | −366,881−8.2% | Reduced |
| EcoR1 Capital, LLC | 4,155,375 | $186.1M | 5.70% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 4,406,456 | $197.4M | 0.02% | +583,238+15.3% | Added |
| Vanguard Group Inc | 4,514,478 | $202.2M | 0.00% | +939,402+26.3% | Added |
| Wellington Management Group LLP | 4,620,413 | $206.9M | 0.04% | +1,648,831+55.5% | Added |
| Driehaus Capital Management LLC | 6,112,173 | $273.8M | 2.65% | +885,876+17.0% | Added |
| BlackRock Inc. | 6,230,371 | $279.1M | 0.01% | +794,267+14.6% | Added |
| Vivo Capital, LLC | 0 | $0 | 0.00% | −350,000−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −210,000−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −153,395−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −127,835−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −88,005−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −32,509−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −11,100−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −7,841−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −7,100−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −4,887−100.0% | Sold out |
| Oppenheimer Asset Management Inc. | 0 | $0 | 0.00% | −4,276−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −3,573−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −3,352−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −2,114−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −245−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |